Pharma Mar SA (PHMMF)
96.00
0.00 (0.00%)
USD |
OTCM |
Apr 02, 16:00
Pharma Mar EPS Diluted (Quarterly) : 3.978 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Grifols SA | 0.168 |
| Oryzon Genomics SA | -0.0202 |
| Laboratorios Farmaceúticos Rovi SA | 0.9711 |
| Almirall SA | -- |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 69.45M |
| Revenue (Quarterly) | 105.31M |
| Total Expenses (Quarterly) | 35.86M |
| Enterprise Value | 1.525B |
| Gross Profit Margin (Quarterly) | 93.59% |
| Profit Margin (Quarterly) | 65.95% |
| Earnings Yield | 5.18% |
| Operating Earnings Yield | 2.79% |
| Normalized Earnings Yield | 5.183 |